Showing results (121-130 of 182) with videos related to

Sort By:
Pageof 19
Endocrinology|July 1, 1990
Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH2 by substitution of PTH amino acids at positions 10 and 11R F Nutt, M P Caulfield, J J Levy, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 4, 2014
The measurement of 3-epimer 25-hydroxyvitamin D by mass spectrometry in clinical specimens detects inconsequential levels in adult subjectsMildred M Goldman, Khanh V Viec, Michael P Caulfield, et al.
Acta Mechanica|November 26, 2025
Pairwise interaction of in-line spheroids settling in a linearly stratified fluidAbdullah M Abdal, Lyes Kahouadji, Seungwon Shin, et al.
Biochemistry|April 28, 1992
Synthesis of fully active biotinylated analogues of parathyroid hormone and parathyroid hormone-related protein as tools for the characterization of parathyroid hormone receptorsE Roubini, L T Duong, S W Gibbons, et al.
Endocrinology|August 1, 1995
Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34)D Leaffer, M Sweeney, L A Kellerman, et al.
Journal of Cellular Physiology|October 1, 1992
Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by down-regulating parathyroid hormone receptorsM S Katz, G E Gutierrez, G R Mundy, et al.
The Journal of Physiology|June 15, 1994
Muscarinic M-current inhibition via G alpha q/11 and alpha-adrenoceptor inhibition of Ca2+ current via G alpha o in rat sympathetic neuronesM P Caulfield, S Jones, Y Vallis, et al.
Biochemistry|June 18, 1991
Cyclic parathyroid hormone related protein antagonists: lysine 13 to aspartic acid 17 [i to (i + 4)] side chain to side chain lactamizationM Chorev, E Roubini, R L McKee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
Biochemical and morphological characterization of basophilic leukocytes from two patients with myelogenous leukemiaM E Rothenberg, J P Caulfield, K F Austen, et al.
Circulation|November 19, 2013
Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)Amit V Khera, Brendan M Everett, Michael P Caulfield, et al.
Pageof 19